kt 5823 has been researched along with minocycline in 1 studies
| Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (minocycline) | Trials (minocycline) | Recent Studies (post-2010) (minocycline) |
|---|---|---|---|---|---|
| 317 | 0 | 59 | 6,579 | 502 | 2,921 |
| Protein | Taxonomy | kt 5823 (IC50) | minocycline (IC50) |
|---|---|---|---|
| Multidrug transporter MdfA | Escherichia coli K-12 | 2.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SD; Hwang, CS; Tang, CM; Yang, DI | 1 |
1 other study(ies) available for kt 5823 and minocycline
| Article | Year |
|---|---|
Neuroprotective mechanisms of minocycline against sphingomyelinase/ceramide toxicity: Roles of Bcl-2 and thioredoxin.
Topics: Animals; Blotting, Western; Carbazoles; Cells, Cultured; Ceramides; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic GMP-Dependent Protein Kinases; Dinitrochlorobenzene; Genes, bcl-2; Minocycline; Neurons; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxadiazoles; Proto-Oncogene Proteins c-bcl-2; Quinoxalines; Rats; Rats, Sprague-Dawley; Signal Transduction; Sphingomyelin Phosphodiesterase; Thioredoxins | 2011 |